Cargando…
Prostate cancer between prognosis and adequate/proper therapy
Knowing the indolent, non-invasive nature of most types of prostate cancer, as well as the simple fact that the disease seems more likely to be associated with age rather than with other factors (50% of men at the age of 50 and 80% at the age of 80 have it [1], with or without presenting any symptom...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304372/ https://www.ncbi.nlm.nih.gov/pubmed/28255369 |
_version_ | 1782506872768561152 |
---|---|
author | Grozescu, T Popa, F |
author_facet | Grozescu, T Popa, F |
author_sort | Grozescu, T |
collection | PubMed |
description | Knowing the indolent, non-invasive nature of most types of prostate cancer, as well as the simple fact that the disease seems more likely to be associated with age rather than with other factors (50% of men at the age of 50 and 80% at the age of 80 have it [1], with or without presenting any symptom), the big challenge of this clinical entity was to determine severity indicators (so far insufficient) to guide the physician towards an adequate attitude in the clinical setting. The risk of over-diagnosing and over-treating many prostate cancer cases (indicated by all the major European and American studies) is real and poses many question marks. The present paper was meant to deliver new research data and to reset the clinical approach in prostate cancer cases. |
format | Online Article Text |
id | pubmed-5304372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Carol Davila University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53043722017-03-02 Prostate cancer between prognosis and adequate/proper therapy Grozescu, T Popa, F J Med Life Reviews Knowing the indolent, non-invasive nature of most types of prostate cancer, as well as the simple fact that the disease seems more likely to be associated with age rather than with other factors (50% of men at the age of 50 and 80% at the age of 80 have it [1], with or without presenting any symptom), the big challenge of this clinical entity was to determine severity indicators (so far insufficient) to guide the physician towards an adequate attitude in the clinical setting. The risk of over-diagnosing and over-treating many prostate cancer cases (indicated by all the major European and American studies) is real and poses many question marks. The present paper was meant to deliver new research data and to reset the clinical approach in prostate cancer cases. Carol Davila University Press 2017 /pmc/articles/PMC5304372/ /pubmed/28255369 Text en ©Carol Davila University Press This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Reviews Grozescu, T Popa, F Prostate cancer between prognosis and adequate/proper therapy |
title | Prostate cancer between prognosis and
adequate/proper therapy
|
title_full | Prostate cancer between prognosis and
adequate/proper therapy
|
title_fullStr | Prostate cancer between prognosis and
adequate/proper therapy
|
title_full_unstemmed | Prostate cancer between prognosis and
adequate/proper therapy
|
title_short | Prostate cancer between prognosis and
adequate/proper therapy
|
title_sort | prostate cancer between prognosis and
adequate/proper therapy |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304372/ https://www.ncbi.nlm.nih.gov/pubmed/28255369 |
work_keys_str_mv | AT grozescut prostatecancerbetweenprognosisandadequatepropertherapy AT popaf prostatecancerbetweenprognosisandadequatepropertherapy |